Abstract
INTRODUCTION: Kinases are essential for cellular regulation and drug development. Predicting the quantitative binding affinity between small-molecule compounds and kinases remains a challenge because of data complexity. METHOD: We developed DeepKinome, a 20-layer convolutional neural network-based deep learning (DL) regression model, to predict quantitative binding affinity. Given the continuous nature of binding affinity, the root mean square error (RMSE), the coefficient of determination (R(2)), the Pearson's correlation coefficient (PCC) between actual and predicted values, and the acceptance interval ratio (AIR) were evaluated. Trained using data from 234 kinases and 163 compounds from the L1000 database. RESULTS: DeepKinome outperformed five DL and four machine learning models, achieving an RMSE of 1.157, an R(2) of 0.535, a PCC of 0.743, and an AIR of 0.570. Explainable artificial intelligence analysis revealed key amino acid sequences that influenced the predictions aligned with known kinase phosphorylation sites. CONCLUSION: DeepKinome offers a promising approach for understanding kinase inhibition and compound binding.